| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/07/2010 | EP2203176A2 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| 07/07/2010 | EP2203060A1 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 07/07/2010 | EP1682178B1 Methods of therapy for cancers expressing the cd40 antigen |
| 07/07/2010 | EP1670785B1 Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 07/07/2010 | EP1334201B1 Dna expression vectors |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/07/2010 | EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response |
| 07/07/2010 | CN101772507A proteasome inhibitors |
| 07/07/2010 | CN101772502A (7H-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 07/07/2010 | CN101772501A Heterocyclic compounds and use thereof as ERK inhibitors |
| 07/07/2010 | CN101772500A Imidazopyrazines as protein kinase inhibitors |
| 07/07/2010 | CN101772353A Oxidized avidin with high residency time in the treated tissues |
| 07/07/2010 | CN101772344A Fulvene and fulvalene analogs and their use in treating cancers |
| 07/07/2010 | CN101768614A Method for efficiently extracting polysaccharide and polyphenol from agaricus blazei |
| 07/07/2010 | CN101768612A Preparation method of nitrobenzene derivatives and application thereof |
| 07/07/2010 | CN101768576A HSV1-TK (herpes simplex virus type 1-thymidine kinase) gene recombination oncolytic adenovirus, preparation method and application thereof |
| 07/07/2010 | CN101768219A Recombinant fusion protein and preparing method and application thereof |
| 07/07/2010 | CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof |
| 07/07/2010 | CN101768214A Human tumor marker-Tim17 polypeptide and application thereof |
| 07/07/2010 | CN101768211A HN protein and F protein of newcastle disease virus Italien strain and application thereof in gene therapy medicament |
| 07/07/2010 | CN101768202A Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof |
| 07/07/2010 | CN101768199A Polymorphs of abiraterone acetate and preparation method thereof |
| 07/07/2010 | CN101768197A Preparation method for nelarabine |
| 07/07/2010 | CN101768196A Synthesizing process of capecitabine |
| 07/07/2010 | CN101768195A Iodinated linoleic acid deoxidation fluorouracil glucoside ester, preparation method and application thereof |
| 07/07/2010 | CN101768183A Acetylpyridine-5-chloric salicylacylhydrazone triphenyhin chloride coordination compound and preparation method and application thereof |
| 07/07/2010 | CN101768182A Acetylpyridine-5-chloric salicylacylhydrazone dibutyltin dichloride coordination compound and preparation method and application thereof |
| 07/07/2010 | CN101768173A Norcantharidin dimer derivate as well as synthetic method and application thereof |
| 07/07/2010 | CN101768157A Amantadine pidotimod carboxylate and preparation method and application thereof |
| 07/07/2010 | CN101768156A Pidotimod arginine salt and preparation thereof |
| 07/07/2010 | CN101768155A Derivatives containing (aminomethyl-five-membered heterocyclo-4-carbonyl)-pyrrolidine-2-carboxylic acid, preparation method thereof and use thereof |
| 07/07/2010 | CN101768130A Derivatives containing aminomethyl-5-membered aromatic heterocycle-4-carboxylic acid, preparation method, drug combination and application thereof |
| 07/07/2010 | CN101768097A Method for preparing selenic acid arginine and application of selenic acid arginine |
| 07/07/2010 | CN101768081A Inhibitor of fatty acid synthase and application thereof |
| 07/07/2010 | CN101768079A Compound and medicinal application thereof |
| 07/07/2010 | CN101766821A Application of polymer based on beta-cyclodextrin |
| 07/07/2010 | CN101766818A Polysaccharide gold-magnetic composite particle medicine carrier and preparation method thereof |
| 07/07/2010 | CN101766817A Medicine carrier and application thereof |
| 07/07/2010 | CN101766799A Ginseng-monkshood centipede health wine |
| 07/07/2010 | CN101766756A Chinese herbal medicine for cancer treatment |
| 07/07/2010 | CN101766690A Multipurpose utilization method for improving the value of schisandra chinensis medicinal material |
| 07/07/2010 | CN101766682A Process for extracting and purifying total alkaloids of Sophora alopecuroides |
| 07/07/2010 | CN101766680A Comprehensive extraction method of glycyrrhiza |
| 07/07/2010 | CN101766679A Application of flavonoids of astragali complanali in preparing anti-aging medicaments and antileukemie medicaments |
| 07/07/2010 | CN101766670A Rhodiola rosea polyphenol microcapsule and preparation method |
| 07/07/2010 | CN101766662A Process for efficiently concentrating cordycepin |
| 07/07/2010 | CN101766644A Fungus polysaccharide composition with anticancer effect and preparation method thereof |
| 07/07/2010 | CN101766633A Application of cucurbitacin in preparation of medicament for treating cancer |
| 07/07/2010 | CN101766619A Pharmaceutical composite for malignancy treatment and application thereof |
| 07/07/2010 | CN101766616A Compound for effectively removing cancer cells |
| 07/07/2010 | CN101766604A Preparation method and pharmaceutical uses of curcumin and pidotimod composition |
| 07/07/2010 | CN101766603A Intramuscular injection solution for enhancing immunity |
| 07/07/2010 | CN101766602A Application of substituted aryl hydrazone compound serving as anti-tumor necrosis factor inhibitor medicament |
| 07/07/2010 | CN101766599A Drug combination preparation containing qidimacrin or medicinal composites thereof |
| 07/07/2010 | CN101766589A Application of compound of 2-methyl valeric acid ion polymer to preparation of antineoplastic medicament |
| 07/07/2010 | CN101766570A PH-sensitive precursor cation nanometer liposome of target tumour cell and preparation method thereof |
| 07/07/2010 | CN101362736B Benzenesulfonamides Ca-4 analogue, synthesis method and application |
| 07/07/2010 | CN101039939B Quinazolinylmethylene thiazolinones as CDK1 inhibitors |
| 07/07/2010 | CN101032532B Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof |
| 07/07/2010 | CN101015545B Use of phenylpropionic acid and phenyl propyl compound with oxidation resistance function for protecting liver and brain damage |
| 07/07/2010 | CN101015544B Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage |
| 07/06/2010 | US7750181 Antiproliferative agents |
| 07/06/2010 | US7750152 Preparing 1-methyl,2-oxo,3-ethyl,4-cyclopentyl,6-chloro-1,2,3,4-tetrahydropteridine by reacting ethyl 2-N-cyclopentylaminobutyrate hydrochloride with 2,4-dichloro-5-aminopyrimidine; reducing, cyclizing and methylating by electrolytic substitution; antiproliferative, -carcinogenic and -tumor agents |
| 07/06/2010 | US7750151 Inhibitors of Akt activity |
| 07/06/2010 | US7750150 Process for producing acid adduct salt of polyacidic base compound |
| 07/06/2010 | US7750138 consisting of different fragments of the VEGF receptors FLT-1 and KDR and human immunoglobulin Fc; treatment of angiogenesis-related diseases including tumor, diabetic retinopathies, arthritis, anemia and endometrial hyperplasia; vectors; host cell |
| 07/06/2010 | US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells |
| 07/06/2010 | US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects |
| 07/06/2010 | US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |
| 07/06/2010 | US7750024 [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid, 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one, or 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline; AMPA receptor antagonist; anticarcinogenic agents |
| 07/06/2010 | US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 07/06/2010 | US7750007 Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors |
| 07/06/2010 | US7750001 2-(2-methylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; phosphatidylinositol 3-kinase (PI3K) inhibitor; transplantation of organs or tissues, inflammatory bowel diseases, psoriasis or atopic dermatitis, chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, scleroderma |
| 07/06/2010 | US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 07/06/2010 | US7749988 Triterpenoid derivatives |
| 07/06/2010 | US7749758 Human and mammalian stem cell-derived neuron survival factors |
| 07/06/2010 | US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies |
| 07/06/2010 | US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 07/06/2010 | US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
| 07/06/2010 | US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/06/2010 | US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749534 chemotherapeutical agent comprising cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) or salts and/or derivatives thereof in the form of capsules, tablets, creams, ointments and infusion solutions; antitumor agents |
| 07/06/2010 | US7749495 Method for inducing an anti-tumor and anti-cachexia immune response in mammals |
| 07/06/2010 | CA2522761C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 07/06/2010 | CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/06/2010 | CA2446149C Vitamin d analogues |
| 07/06/2010 | CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/06/2010 | CA2382129C Novel derivatives of flavones, xanthones and coumarins |
| 07/06/2010 | CA2359462C Pyrazole compounds and uses thereof |
| 07/06/2010 | CA2288059C Method of treating malignancies |
| 07/06/2010 | CA2286091C Polymer-platinum compounds |
| 07/06/2010 | CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |